Brazil Next Generation Cancer Diagnostics Market Size & Outlook

The next generation cancer diagnostics market in Brazil is expected to reach a projected revenue of US$ 1,042.8 million by 2030. A compound annual growth rate of 9.8% is expected of Brazil next generation cancer diagnostics market from 2024 to 2030.

Revenue, 2023 (US$M)
$541.7
Forecast, 2030 (US$M)
$1,042.8
CAGR, 2024 - 2030
9.8%
Report Coverage
Brazil

Brazil next generation cancer diagnostics market highlights

  • The Brazil next generation cancer diagnostics market generated a revenue of USD 541.7 million in 2023 and is expected to reach USD 1,042.8 million by 2030.
  • The Brazil market is expected to grow at a CAGR of 9.8% from 2024 to 2030.
  • In terms of segment, next generation sequencing was the largest revenue generating technology in 2023.
  • Next Generation Sequencing is the most lucrative technology segment registering the fastest growth during the forecast period.


Next generation cancer diagnostics market data book summary

Market revenue in 2023USD 541.7 million
Market revenue in 2030USD 1,042.8 million
Growth rate9.8% (CAGR from 2023 to 2030)
Largest segmentNext generation sequencing
Fastest growing segmentNext Generation Sequencing
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationNext Generation Sequencing, QPCR & Multiplexing, LOAC & RT-PCR, Protein Microarrays, DNA Microarrays
Key market players worldwideJohnson & Johnson, Illumina Inc, Novartis AG ADR, Roche, Koninklijke Philips NV, Qiagen NV, Agilent Technologies Inc, Abbott Laboratories, Thermo Fisher Scientific Inc, GE HealthCare Technologies Inc Common Stock


Other key industry trends

  • In terms of revenue, Brazil accounted for 3.4% of the global next generation cancer diagnostics market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Latin America, Brazil next generation cancer diagnostics market is projected to lead the regional market in terms of revenue in 2030.
  • Brazil is the fastest growing regional market in Latin America and is projected to reach USD 1,042.8 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Next Generation Cancer Diagnostics Market Scope

Next generation cancer diagnostics market segmentation & scope
Next Generation Sequencing
qPCR & Multiplexing
LOAC & RT-PCR
Protein Microarrays
DNA Microarrays
Biomarker Development
CTC Analysis
Proteomic Analysis
Epigenetic Analysis
Genetic Analysis
Lung Cancer
Breast Cancer
Colorectal Cancer
Cervical Cancer
Others
Theapeutic Monitoring
Companion Diagnostics
Prognostics
Cancer Screening
Risk Analysis

Next Generation Cancer Diagnostics Market Companies

Name Profile # Employees HQ Website

Brazil next generation cancer diagnostics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to next generation cancer diagnostics market will help companies and investors design strategic landscapes.


Next generation sequencing was the largest segment with a revenue share of 36.88% in 2023. Horizon Databook has segmented the Brazil next generation cancer diagnostics market based on next generation sequencing, qpcr & multiplexing, loac & rt-pcr, protein microarrays, dna microarrays covering the revenue growth of each sub-segment from 2018 to 2030.


Concentration of more investments for sequencing and data analysis services in the South-eastern region of the country as a consequence of availability of resources is anticipated to propel growth of this region in diagnostics sector. 

Additionally, technology boom in Sao Paulo with respect to computer resources and web development is expected to impact the growth in data analysis segment of NGS technology.

The Brazilian population Based Registry (PBCR) with its twenty establishments across the country has analyzed that there were high cancer incidences between 92 to 220 children/adolescents per 100,000, and children between the ages of 1-4 years.

Reasons to subscribe to Brazil next generation cancer diagnostics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Brazil next generation cancer diagnostics market databook

  • Our clientele includes a mix of next generation cancer diagnostics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Brazil next generation cancer diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Brazil next generation cancer diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Brazil next generation cancer diagnostics market size, by technology, 2018-2030 (US$M)

Brazil Next Generation Cancer Diagnostics Market Outlook Share, 2023 & 2030 (US$M)

Brazil next generation cancer diagnostics market size, by technology, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more